Every two seconds someone in the United States needs blood or platelets for lifesaving care. From trauma and surgery to ...

The organisation explains that O-negative blood serves as a universal donor type, making it the primary choice for critical ...

Anemia and transfusion of red blood cells are common in patients undergoing valve surgery for infective endocarditis, and ...

Takeda and Protagonist Therapeutics have submitted a new drug application to the FDA for rusfertide for adults with ...

About one in five patients with cancer who undergo genetic testing are incidentally found to have mutations in their blood ...

You usually won’t find out blood type or subtype until you give blood for the first time. After signing up to donate and ...

About 1 in 5 patients with cancer who undergo genetic testing are incidentally found to have mutations in their blood called ...

Large wild mammals—from elephants to antelopes—are already struggling to cope with global warming. Now new research shows ...

Takeda & Protagonist submit NDA to US FDA seeking approval for rusfertide to treat polycythemia vera: Osaka, Japan Wednesday, January 7, 2026, 17:00 Hrs [IST] Takeda, focused on c ...

African striped mice are used to desert conditions but are showing dehydration as climate change heats up their environment.

Preliminary but promising.Those three words emerged as a recurring theme in conversations about several abstracts presented at this year’s ASH Annual Meeting and Exposition that examined the effects ...

Takeda (TSE:4502/NYSE:TAK) and Protagonist Therapeutics (Nasdaq: PTGX) (“Protagonist”) announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking ...